EResearch Posts Perspective on Microbix Biosystems Inc. - WLTZ 38 | Columbus Georgia Regional News & Community

EResearch Posts Perspective on Microbix Biosystems Inc.

Posted: Updated:

Microbix

Biosystems Inc. focuses on developing and commercializing biological products

and technologies through leveraging its Core Base Business of developing

infectious disease antigens (virology) for sale to large diagnostic kit

manufacturers.

The Company has reported Q4 and full-year F2013

results, with revenue for F2013 up 14% compared with F2012. Microbix

has provided updates on its thrombolytic drug Kinlytic™ (Urokinase)

as well as announcing patent litigation against Novartis Vaccines and

Diagnostics.

Read more in the Perspective here: Microbix Biosystems

eResearch

is a primary source for professional investment research, focused on small- and

mid-cap companies. Our research and analysis is of institutional quality, and

has the potential for reaching millions of global investors through our

extensive electronic distribution network.

eResearch

posts all its reports and articles on its website, eresearch.ca,

and subscription is FREE.

Contact:

eResearch: Bob Weir, CFA,

Director of Research
Telephone:

(416) 703-6258
email: bweir@eresearch.ca

Source: http://www.accesswire.com/viewarticle.aspx?id=410821

ReleaseID: 30446

Powered by WorldNow
Powered by WorldNow All content © Copyright 2000 - 2014 WorldNow and WLTZ. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.